Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03241433 · ClinicalTrials.gov registry record · NA

High-Intensity Aerobic Lifelong Training--AF

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03241433: Completed NA study, sponsored by University of Minnesota.

NCT03241433 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03241433, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study is a single-center RCT. Potential subjects with symptomatic non-permanent AF will be enrolled to determine the effect of sprint interval training (SIT) in comparison to moderate-intensity continuous training (MICT) and non-exercise control in reducing AF burden. The Investigators will enroll 60 patients during the first 12 months of the study. Baseline data collection will be conducted during the first month after enrollment. After baseline data collection, subjects will be randomized (1:1:1) to SIT vs. MICT vs. non-exercise controls. The exercise training will last for 3 months followed by final data collection which will be completed in 1 month.

Primary Outcome

After 12 weeks of exercise training , HIIT and MICT will be comparable but better than non-exercise control in AFburden(% of time a person is in AF) by using an ambulatory patch monitor

Interventions

  • OTHER No Exercise
  • OTHER High intensity interval training
  • OTHER Moderate intensity continuous training

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-05-01
Est. Completion 2019-12-18
Phase NA
University of Minnesota

966 total trials

What the finished NCT03241433 record still lists

NCT03241433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which No Exercise is the first listed.

NCT03241433 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03241433 about?

NCT03241433 is a clinical study titled "High-Intensity Aerobic Lifelong Training--AF". This study is a single-center RCT. Potential subjects with symptomatic non-permanent AF will be enrolled to determine the effect of sprint interval training (SIT) in comparison to moderate-intensity continuous training (MICT) and non-exercise control in reducing AF burden. The Investigators will enr...

What is the current status of trial NCT03241433?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-05-01. Estimated completion is 2019-12-18.

What interventions are being tested in trial NCT03241433?

The interventions under investigation include: No Exercise (OTHER), High intensity interval training (OTHER), Moderate intensity continuous training (OTHER).

Who is sponsoring clinical trial NCT03241433?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03241433's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03241433, the US trial registry maintained by the National Library of Medicine. NCT03241433 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.